Atlas Trials

First-in-Human Study of MS201408-0005A as Single Agent and in Combinations

Clinical trial NCT03306420 · TERMINATED

Trial details

NCT number
NCT03306420
Sponsor
EMD Serono Research & Development Institute, Inc.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic or Locally Advanced Unresectable Solid Tumors
Start date
2017-10-03
Primary completion
2019-01-14
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.